AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$25,000
+4.96%
Shares
Shares Volume: 25,000 Shares
Average Share Price: $1
INSIDER
Zakrzewski Joseph S
Director
reported on Nov 20 2024
traded on Nov 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 529,079 |
| PURCHASES/SALES 1Y | 1 / 1 |
| P/S VALUE RATIO | 0.013 |
| AVERAGE PURCHASE VALUE | $25,000 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 2 / 0 |
| PURCHASES/SALES 1Y | 3 / 11 |
| P/S VALUE RATIO | 0.163 |
| AVERAGE PURCHASE VALUE | $545,000 |
| COMPANY PREVIOUS TRADES |